EDGAR Filing Documents for 0001558370-24-011971

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001558370-24-011971

Filing Date

2024-08-13

Accepted

2024-08-13 06:45:45

Documents

108

Period of Report

2024-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	jagx-20240630x10q.htm iXBRL	10-Q	3901361
2	EX-31.1	jagx-20240630xex31d1.htm	EX-31.1	11009
3	EX-31.2	jagx-20240630xex31d2.htm	EX-31.2	11008
4	EX-32.1	jagx-20240630xex32d1.htm	EX-32.1	6965
5	EX-32.2	jagx-20240630xex32d2.htm	EX-32.2	6940
	Complete submission text file	0001558370-24-011971.txt		16482576

Data Files

Seq	Description	Document	Type	Size
6	EX-101.SCH	jagx-20240630.xsd	EX-101.SCH	114424
7	EX-101.CAL	jagx-20240630_cal.xml	EX-101.CAL	72928
8	EX-101.DEF	jagx-20240630_def.xml	EX-101.DEF	526285
9	EX-101.LAB	jagx-20240630_lab.xml	EX-101.LAB	832891
10	EX-101.PRE	jagx-20240630_pre.xml	EX-101.PRE	711035
111	EXTRACTED XBRL INSTANCE DOCUMENT	jagx-20240630x10q_htm.xml	XML	3222857

Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104

Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300

Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)